BioPharma Solutions
Proprietary Intelligence
Our global team of investigative journalists provides subscribers with a daily stream of proprietary intelligence predicting market-moving events 6-12 months in advance:
Gain an Information Edge
Using exclusive Active Intel technology, BioPharm Insight transforms traditional market research into actionable intelligence by seamlessly integrating forward-looking articles with our powerful databases of market analytics and key contacts. This enables subscribers to take action on market developments months or even years before it breaks in mainstream media.
Direct from the Experts
The BioPharm Insight investigative journalism team delivers unique value through exclusive interviews with relevant and active key opinion leaders, clinical investigators, doctors, researchers, lawyers, investors and C-level executives – anyone with critical information on the topic being investigated. Typically, each article includes confirming opinions from at least four independent sources to ensure clients are reacting to reliable and trustworthy intelligence.
Unbiased Coverage
Because the investigative journalism team is completely independent from the business of BioPharm Insight, topics covered are free from influences and potential conflicts of interest inherent to many traditional publications which rely on advertising funds for revenue as a key part of their business model. This ensures our reliable and objective intelligence focuses exclusively on the key developments that matter most to the industry and appeals to a wide range of professionals at biopharma companies, CROs and service providers, and financial markets firms.
Media Partnerships
BioPharm Insight reporters are often found moderating expert panels at major scientific and investor conferences around the world and covering the events in real time for subscribers with forward-looking intelligence. If you manage an event and would like to request coverage, This e-mail address is being protected from spambots. You need JavaScript enabled to view it. .
Begin a Conversation
Contact us to discover the type of actionable insight you will receive from our investigative journalist team.